|
Name: Betameprodine
Type: Opioid analgesic
AKA: N/A
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Betameprodine, an opioid analgesic, was developed in the mid-20th century. It is used for pain relief and is part of the broader category of opioids used in medical treatments.
|
|
V. Legal Information
Betameprodine, an opioid analgesic, is classified as a Schedule I controlled substance in the US, making it illegal. Its high potential for abuse and lack of accepted medical use lead to similar bans in many countries. The UNODC and other regulatory bodies emphasize strict control measures to prevent misuse and address the opioid crisis.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Betameprodine is a synthetic opioid with potent analgesic effects. It causes sedation, respiratory depression, and constricted pupils, acting as a downer. Short-term use is effective for pain management, but long-term use can lead to addiction, tolerance, and severe health issues. Overdose risks include fatal respiratory depression. Safe use involves strict dosing and medical supervision. Recent research highlights its potency and compares its risks with other opioids.  |
|
VII. Psychological Effects
Betameprodine, a synthetic opioid, induces euphoria, sedation, and significant pain relief. Immediate effects include mood elevation and cognitive impairment. Long-term use can result in addiction, tolerance, and withdrawal symptoms. Chronic use is associated with mood disorders, cognitive decline, and high overdose risk. Recent research highlights its potent effects and risks similar to other opioids.
 |
|
VIII. Culture
Betameprodine is a synthetic opioid with no historical lore, becoming significant in the 20th century for pain management. Its role in discussions about opioid potency and regulation reflects broader concerns about addiction. Proponents highlight its effectiveness in pain relief, while opponents focus on its potential for misuse. Its use is primarily medicinal, reflecting ongoing debates in opioid management.
 |